POET Technologies (POET) Earnings Date & Reports

Key Takeaways

• Revenue reached $503,389, up significantly from $166,760 in Q1 2025 and beating analyst estimates of $250,000.
• Net loss totaled $12.3 million, or ($0.08) per share, missing consensus EPS estimate of ($0.05).
• Research and development expenses rose slightly to $4.5 million, reflecting continued investment in photonic technologies.
• Stock-based compensation of $3.4 million and depreciation of $1.0 million contributed to the quarterly results.
• Operating cash flow remained stable at approximately ($8.8) million, similar to the prior-year period.
• Next earnings report for Q2 2026 is expected in mid-August 2026.

Earnings Context and Why It Matters

POET Technologies develops photonic integrated circuits and optical modules for artificial intelligence and data center applications. The Q1 2026 results provide the first look at financial performance following the company’s fiscal year-end transition and recent capital raises. Investors closely monitor these reports for signs of commercial traction in a rapidly expanding photonics market, where revenue ramp-up and cost management are critical to long-term viability.

Reported Results

POET Technologies reported Q1 2026 revenue of $503,389, more than triple the $166,760 recorded in the same quarter a year earlier. This figure exceeded analyst consensus expectations. The company posted a net loss of $12.3 million, or ($0.08) per share, compared with a net income of $6.3 million in Q1 2025. The loss widened partly due to higher non-cash expenses, including $3.4 million in stock-based compensation. Revenue primarily stemmed from non-recurring engineering services. No updated financial guidance was provided in the release.

AI Screener

The AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. AI Screener

Market Reaction and Investor Sentiment

Shares of POET Technologies declined approximately 8% in the trading session following the May 14, 2026, earnings release. The mixed results—revenue beat offset by an EPS miss—prompted some profit-taking after prior gains tied to industry momentum in photonics. Trading volume remained elevated, reflecting ongoing investor interest in the company’s technology roadmap.

Forward Outlook and Key Factors to Monitor

Investors will focus on POET’s progress toward securing design wins with major data-center and AI customers. Continued growth in non-recurring engineering revenue could signal accelerating adoption of the company’s photonic integrated circuit platform.

Management’s emphasis on scaling manufacturing partnerships and reducing operating expenses will be watched closely. Cash burn remains a key metric, with the company maintaining a stable quarterly outflow near $8.8 million.

Upcoming catalysts include potential announcements on commercial orders and the Q2 2026 earnings report expected in mid-August. Industry demand for high-speed optical interconnects in AI infrastructure continues to provide a favorable backdrop, though execution on cost control and revenue diversification will determine POET’s ability to narrow losses over the coming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.